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China
Brucella is a facultative intracellular pathogen that causes zoonotic infection known as
brucellosis which results in abortion and infertility in natural host. Humans, especially
in low income countries, can acquire infection by direct contact with infected animal
or by consumption of animal products and show high morbidity, severe economic
losses and public health problems. However for survival, host cells develop complex
immune mechanisms to defeat and battle against attacking pathogens and maintain
a balance between host resistance and Brucella virulence. On the other hand as a
successful intracellular pathogen, Brucella has evolved multiple strategies to evade
immune response mechanisms to establish persistent infection and replication within
host. In this review, wemainly summarize the “Stealth” strategies employed by Brucella to
modulate innate and the adaptive immune systems, autophagy, apoptosis and possible
role of small noncoding RNA in the establishment of chronic infection. The purpose of this
review is to give an overview for recent understanding how this pathogen evades immune
response mechanisms of host, which will facilitate to understanding the pathogenesis of
brucellosis and the development of novel, more effective therapeutic approaches to treat
brucellosis.
Keywords: Brucella, “Stealth” strategy, chronic infection, innate immunity, adaptive immunity, autophagy,
apoptosis, small noncoding RNA
INTRODUCTION
Brucella species are the causative agent of brucellosis, among one of major bacterial zoonotic
diseases. Brucella is Gram-negative, non-spore-forming, non-motile, facultative anaerobe and
intracellular in nature which mainly affect the reproductive tract and cause abortion and infertility
in natural host (D’Anastasio et al., 2011). According to host specificity there are 10 species of
Brucella: B. melitensis (natural hosts: goat and sheep), B. abortus (natural host: cattle), B. suis
(natural host: swine), B. canis (natural host: dogs), B. ovis (natural host: sheep), B. neotomae (natural
host: desertmice), B. cetacea (natural host: cetacean), B. pinnipedia (natural host: seal), B. microti
(natural host: voles), and B. inopinata (natural host: unknown; Whatmore et al., 2007). However,
among recognized Brucella species themost pathogenic for human include B. melitensis, B. abortus,
B. suis, and B. canis. In addition, Brucella represent public health problems in low income countries
(Atluri et al., 2011; Martirosyan et al., 2011). Humans can acquire infection by different ways such
as direct contact with diseased animals or by consumption of Brucella affected animal’s products.
Brucella infection in human is considered as a febrile illness that can progress into a long lasting
disease with the appearance of severe complications (de Figueiredo et al., 2015).
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In human and animal brucellosis, persistence occurs in
the tissues of mononuclear phagocyte system including bone
marrow, lymph nodes, liver and spleen. Additionally, in both
human and animal host, Brucella may be encountered within
bones and joints, as well as in male reproductive organs
while in placenta and fetus of females (Atluri et al., 2011;
Martirosyan et al., 2011). If brucellosis is not properly treated,
it develops into chronic infection that leads to severe health
problems resulting in remarkable morbidity and economic loss
in endemic areas (in the Middle East, North, Central and
South America, north Africa, Mediterranean countries, and
countries of the Caucasus and central Asia; Godfroid et al.,
2011). Brucellosis is one of the frequently encountered zoonotic
diseases that infect approximately 500,000 new cases annually
(Durward et al., 2012). Even though there are some commercial
vaccines are used to control animal brucellosis, yet no safe
and effective vaccines are available for humans or pregnant
animals. Generally, occurrence of human brucellosis is directly
linked with natural hosts, and not transmitted from person
to person with exception of two reported cases (Pappas et al.,
2006).
Due to certain complications, such as economic issues, ethical
aspects and practical problems, it is difficult to study brucellosis
in natural hosts, as a consequence mice model is widely used
to study the relationship of immune response mechanism with
brucellosis. The course of murine brucellosis depends upon
bacteria (strain, virulence, dose and inoculation route) and
certain host parameters including breed, genetic background,
age, sex, and physiological status (Grillo et al., 2012). Brucella
infection is divided in three steps: in the first step pathogen
invades host within 2 days of infection, in second step pathogen
replicates within different organs of the reticulo-endothelial and
reproductive systems from 2 days to 3 weeks which is known as
the acute phase of infection, while in the 3rd step, the pathogen
displays differences in the pathology of various tissues and lasts
from up to 6 months to 1 year or more, known as chronic phase
(Martirosyan et al., 2011; Grillo et al., 2012). During chronic
phase, the number of bacteria reaches a maximum level in
spleen and liver (from 7 to 12 weeks), followed by the declining
chronic phase during which number of bacteria decreases and
Brucellae are eliminated from spleen and liver (Martirosyan et al.,
2011; Martirosyan and Gorvel, 2013). In this review, we mainly
summarize the strategies and mechanisms employed by Brucella
to evade the immune response of host as well as implication of
these modulations in the pathogenesis of brucellosis.
BRUCELLA PATHOGENESIS
After internalization, Brucella are challenged with harsh
diverse environment situations. The pathogen develops different
strategies including evasion and resisting intracellular host
defense mechanisms for its adaptation that is predicted by certain
structural components or presence of virulence factors. The
pathogenesis of brucellosis mainly depends upon macrophages,
dendritic cells and placental trophoblasts for its survival and
replication (Copin et al., 2012).
There are many intracellular host defense mechanisms,
among one of them is degradation within the lysosomal
compartments. Brucella control the intracellular trafficking of
their vacuoles, named as the Brucella-containing vacuole (BCV)
to avoid this degradation (Celli et al., 2003). Fusions of
BCVs with membrane elements like endoplasmic reticulum
(ER) ultimately favor a safe replicative niche. Internalization
of smooth Brucella is facilitated in the macrophage cells by
lipid raft attachment to the plasma membrane. EEA-1 and
Rab5 are the markers of early endocytic pathway associated
with the lipid raft containing vacuole. For the maturation
of vacuole, these external lipid rafts high in cholesterol are
converted into Brucellae derived β-1,2-glucans b (von Bargen
et al., 2012). Maturation proceeds with the passage of time
and early markers present on the BCV are displaced to Rab7
and LAMP-1 subsequently with the interaction to the late
endosomal compartments (Figure 1). BCV interact with late
endosomes/lysosomes that control vacuolar acidification and
transcription of various Brucella factors (for example: virB) but
result in inhibition of vacuolar attachment of the proteolytic
enzyme, cathepsin D (Boschiroli et al., 2002). The type IV
secretion system (T4SS) of Brucella that encodes virB operon
thought to be involved in secretion of several putative bacterial
factors and support maturation of the BCV ultimately controls
the intracellular and stealthy lifestyle of the pathogen (Roux
et al., 2007; Dohmer et al., 2014). Furthermore, other key
players that are involved in the intracellular life of Brucella
include the two-component regulatory system BvrS/BvrR, the
cyclic b-glucan, the LuxR-like transcriptional regulator VjbR
and the Brucella lipopolysaccharide (LPS) (Sola-Landa et al.,
1998; Arellano-Reynoso et al., 2005; Weeks et al., 2010).
Recent studies have identified some new players such as the
flagellum-like structure, the transporter-like protein BacA and
phosphatidylcholine required for intracellular survival within
host cells (Roop et al., 2009). In addition to Brucella T4SS,
the CD98hc transmembrane protein is recognized as essential
for intracellular proliferation and modulates different signaling
pathways (Keriel et al., 2015).
Calreticulin is an antigen of endoplasm reticulum that also
favors replication in strict rBCVs (replicative Brucella-containing
vacuole). Autophagy proteins play an important role in the
production of (autophagic Brucella-containing vacuole aBCVs)
and pathogen observed in aBCVs contain LAMP1 at the
later stage after infection (48–72 h). Finally through the lytic
and non-lytic mechanisms, the pathogen is released from the
cell (Boschiroli et al., 2002). However, when Brucella reach
the ER not only provides a safe niche but it also protects
the pathogen from strong bactericidal action of phagocytic
cells. New insight in biology of pathogenesis of brucellosis
shed lights that Brucella utilizes cell-cycle control system
for survival within host intracellular environment similar to
Caulobacter crescentus. Brucella is blocked at the G1 stage
of growth and resumed replication starts again after reaching
within the intracellular compartments (De Bolle et al., 2015).
Correspondingly, Brucella is well equipped to tolerate both
physiologic and metabolic stresses that essential for its virulence
(Kohler et al., 2003).
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FIGURE 1 | Model of Brucella invasion and intracellular trafficking within macrophage cells. Smooth Brucella and lipid rafts interact on the plasma
membrane. Brucella derived β-1,2-glucans help in the conversion of external vacuole lipid rich domains that leads to fusion with lysosomes for replication of bacteria.
This interaction ultimately activates the T4SS proteins. T4SS proteins in the cytosol of host cell facilitate the interaction with the endoplasmic reticulum that converted
into the replicative vacuole. Conversion of the eBCV into rBCV is facilitated by Yip1A dependent activation of IRE1α and results in formation of large vacuoles that
depend upon ATG9 and WIPI. The aBCVs formation is dependent on the autophagy initiation proteins, ULK1, ATG14L and BECLIN1, that complete the intracellular
cycle and finally through lytic and non-lytic mechanisms the pathogen is released from the cell. While the role of the rough Brucella outer membrane protein has been
verified, their internalization and intracellular trafficking is unclear but involved in lysosomal degradation.
BRUCELLA MODULATION OF INNATE
IMMUNE RESPONSE
As an effective pathogen, Brucella has developed well organized
strategies that allow it to evolve and interfere with innate
immune recognition which ultimately favor the environment
for generating adaptive immune response (Diacovich and
Gorvel, 2010). The first line of defense against brucellosis
include phagocytosis by cells (neutrophils, macrophages and
dendritic cells (DC), and natural killer (NK)-cells), different
secretion like cytokines and chemokines, recognition of
molecules typical for microbe’s pathogen-associated molecular
patterns (PAMPs) by pattern-recognition receptors (PRRs), and
activation of the complement system (Diacovich and Gorvel,
2010).
Neutrophils are one of the most significant short-lived
phagocytic cells in innate immune response against microbial
pathogens. However, in brucellosis these cells are not stimulated
for effective degranulation. Even though, this pathogen does
not replicate within these cells, it can survive at initial stage
of infection (Riley and Robertson, 1984) and resists killing
(Barquero-Calvo et al., 2007). Brucella have different defensive
antimicrobial resistance mechanisms against hypohalide,
phospholipase A2, cathelicidin, lysozyme, and defensins like
reactive oxygen intermediates (ROI) and reactive nitrogen
intermediates (RNI) which ultimately help this pathogen during
transportation to lymphoid tissues facilitated by neutrophils
(Nathan and Shiloh, 2000).
The host ability to identify Brucella as Gram negative bacteria
via TLR2, TLR4, and TLR5 are reduced (Iwasaki and Medzhitov,
2004). Consequently, Brucella avoid the generation of specific
host response by displaying wrong “bar code” such as neutrophil
infiltration at the infection site. Brucella have the ability to survive
in vivo that is not increased by NADPH oxidase and neutrophils
(even though it can evade them; Barquero-Calvo et al., 2015).
Other than neutrophils, activated NK cells also kill infected
targets and act as first line of defense against Brucella (Fernandes
et al., 1995). Brucella activate NK cells by inducing antigen
presenting cells to release IL-2 and NK cells are converted into
killer cells by IL-2 activation, secretion of IFN-γ and production
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of IFN-γ which plays an important role in developing a Th1- or
Tc1-like response (Gao et al., 2011).
Macrophages and dendritic cells are considered to be key
elements of the innate immune response against the intracellular
bacteria like Brucella. Within the first few hours after entry, 80-
90% pathogens are killed bymacrophages andDCs, while some of
them reach the replicative niche as surviving-pathogens (Watarai
et al., 2002). Brucella use lipid rafts to enter within both murine
macrophages and human monocytes while it uses PI3-kinase and
TLR4 receptors to enter DCs (Pei et al., 2008).
The innate immune system recognizes pathogens in various
tissues facilitated by PRRs which includes toll-like receptors
(TLRs; Iwasaki andMedzhitov, 2004), Nod-like receptors (NLRs;
Franchi et al., 2008), RIG-like receptors (RLRs), and complement
(Snyderman et al., 1968). By the detection of these receptors,
host cells differentiate bacteria from virus by recognizing PAMPs
(Hoebe et al., 2004). There are some distinctive products in
bacteria such as lipopolysaccharides, flagellin, lipoteichoic acids,
and lipoproteins that are recognized by TLR2, TLR4, TLR6,
TLR1, and TLR5 receptors (Iwasaki and Medzhitov, 2004).
Interaction with bacterial surface carbohydrates (LPS of Gram-
negative bacteria) helps in activation of alternative complement
pathway.
Brucella produces lipid A that has significant functions in
immune evasion mechanism via TLR4. In comparison with other
enterobacterial LPS (C12–C16), the pathogen contains longer
fatty acid residue (C28) and due to this modification in LPS
structure which reduces its endotoxic properties by decreasing
TLR4 agonist action (Lapaque et al., 2009). In B. abortusmutants,
failure in the addition of lipid A with C28 acyl chain consequently
leads to severe inflammatory condition than wild-type parent
strain and contribute to decreased infectivity within BALB/cmice
and in macrophages as well (Parent et al., 2007). In addition to
evasion of TLR4, Brucella produce flagellin which plays a role
in evasion sensing by TLR5 that has no specific TLR5 agonist
domain (Andersen-Nissen et al., 2005).
Brucella use other evasion strategies by suppressing innate
immune signaling other than producing PAMPs with decreased
TLR agonist activity via TIR domain-containing protein
designated as Btp1 in B. abortus and TcpB in B. melitensis.
However, the detailed mechanism of this protein is still
incompletely understood, but evidence suggests that for
binding with TIR domain-containing adaptor protein (TIRAP),
it competes with myeloid differentiation response gene
88 (MyD88) that ultimately facilitates ubiquitination and
degradation of Mal and inhibits both TLR4 and TLR2 signaling
(Figure 2; Snyder et al., 2014). Maturation of the dendritic cells
and production of pro-inflammatory cytokines like IL-12 and
TNF-α after Brucella invasion and internalization is reduced
due to this TLR-inhibition (Salcedo et al., 2008). During the
early stage of infection Btp1/TcpB seems to be important in
the immune-evasive activity, such that at the inoculation site
in immune deficient IRF1 mice, there is no systemic spread by
B. melitensis tcpB mutant. The weakened phenotype of tcpB
mutants for immune-competent mice suggests that Brucella
have ability to evade innate immunity by multiple strategies
(Radhakrishnan et al., 2009).
As a stealth invader, Brucella LPS also play a pivotal
role in reducing deposition of complement constituent C3
(Barquero-Calvo et al., 2007). C3 covalently binds with
hydroxyl residues present on the surface of bacteria. Many
pathogens like Salmonella Typhimurium have free hydroxyl
residues in their O-polysaccharide that favors binding with
C3 while B. abortus has linear homopolymer of 1,2-linked
4,6-dideoxy-4-formamido-alpha-d-mannopyranosyl residues in
its O-polysaccharide (Caroff et al., 1984). Generation of pro-
inflammatory complement products like C3a and C5a is
prevented by C3 binding to Brucella O-antigen. Different studies
have shown O-antigen plays an important role in facilitating
a non-inflammatory response through lipid raft microdomains
and macrophage class A scavenger receptor (SR-A; Kim et al.,
2004). These studies suggest that key strategies used by Brucella
to modulate innate immune mechanism are inhibition to
TLR, complement system and involvement of phagocytic cells.
However, further studies on maturation of DCs in vivo and the
contribution of newly identified protein in the innate immune
response as well as their effect on adaptive immune response
will be required to more fully understand the establishment of
chronic infection.
BRUCELLA IMPRESSIVE MECHANISMS
TO EVADE ADAPTIVE IMMUNE RESPONSE
Even though innate immunity efficiently controls the replication
of Brucella at acute phase of infection, a well-organized
adaptive immune response is also essential for the chronic
stage (Baldwin and Goenka, 2006). Furthermore, Brucella has
developed multiple strategies to defeat host defense mechanisms
and consequently confirm the establishment of chronic infection
(Monack et al., 2004).
For the initiation and control of adaptive immune responses,
some cells such as DCs play a significant role (Kapsenberg, 2003).
On the other hand, intracellular pathogens have established
multiple mechanisms to challenge the function of DCs that
ultimately facilitates the pathogen’s entry into the host. Brucella
has established several strategies which confirm its shifting from
innate immune system to the adaptive immune system for
evasion into the host immune machinery. Some recent evidence
have confirmed the efficient proliferation of this pathogen within
DCs both in vitro (Archambaud et al., 2010) and in vivo (Salcedo
et al., 2008). Besides the proliferation, hindrance of maturation of
DCs by B. abortus 2308 and B. suis 1330 also reported by in vitro
studies (Billard et al., 2007; Salcedo et al., 2008). In addition, prior
studies have shown that expression of MHC class II, CD80 and
CD86 were decreased in the Brucella infected DCs. Incompetent
antigen presentation to naïve T cells and inhibition of maturation
result in inhibiting secretion of pro-inflammatory cytokines such
as IL-12 band TNF-α (Billard et al., 2007). In long lasting
vaccine induced immunity, memory adaptive immune responses
are important. For clearance of Brucella, IFN-γ-mediated type I
immune responses are essential (Goenka et al., 2011). Brucella
modulates MHC-I and MHC-II expression prompted by IFN-
γ, a mechanism that depends on cytokine regulation (Gentilini
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et al., 2015), which results in inhibition of MHC-I and MHC-II
molecules (Barrionuevo et al., 2008, 2013).
In brucellosis, adaptive immune response mechanisms are
divided in three main steps: in the first step it inhibit the
intracellular survival of Brucella, IFN-γ produced by CD4+,
CD8+, and T cells which initiates the bactericidal function
in macrophages. Secondly, infected macrophages are killed
which lead to cytotoxicity by CD8+, and T cells. Thirdly, in
the endocytic compartments opsonization of Brucella occur
by IgG2a and IgG3 to enhance phagocytosis (Goenka et al.,
2011; Martirosyan et al., 2011). Additionally, IL-12, IFN-γ, and
TNF-α are key cytokines in brucellosis, initiating innate and
adaptive immune response and giving directions to immune-
associated cells (Martirosyan et al., 2011; Durward et al., 2012).
Furthermore, Brucella LPS also successfully enhances Th1-type
cytokine response such as IL-10 and IFN-γ (Kianmehr et al.,
2015) while 5-Lipoxygenase down regulates the manifestation of
Th-1 immune response particularly IL-12 in Brucella infection in
macrophages (Fahel et al., 2015).
Brucella has a unique property to survive within
the host which results in the establishment of chronic
infection. Therefore, strong immune regulation events are
essentially required in brucellosis. In chronic brucellosis,
immunosuppressive state establishes with the concomitant
increase of CD4+, CD25+ T cells in spleen, which ultimately
plays a significant role in the regulation of effector T lymphocytes
(Pasquali et al., 2010). These murine CD4+ or CD25+ T cells
encourage the elimination of Brucella from infected by antibody
depletion (Pasquali et al., 2010). In comparison MHC class II
and CD4+ Ab-deficient mutant mice are more able to eliminate
Brucella than in wild type mice. The decrease of Møs and DCs
recruitment causes reduced activation of CD8+ T lymphocytes
that results in immunosuppression (Hort et al., 2003) and
deficient clearance of Brucella from spleens, lymph nodes and
livers (Rolan and Tsolis, 2007).
In addition to this, Brucella interfere with the establishment
of protective Th1 immune response by avoiding secretion of IL-
12 and preventing the T-cell stimulatory action of infected DCs
(Salcedo et al., 2008). As a result, maturation capacity of DCs
is reduced and characterized by decreased expression of MHC
class II indicating co-stimulatory molecules on the external cell
surface are necessary to present exogenous protein antigens to
particular T cells (Billard et al., 2007; Salcedo et al., 2008). Mature
DCs are capable of having unique tolerogenic properties, and
Brucella inhibits complete activation DCs by using this property
to subvert immune responses. There is certain evidence that
suggests that initiation of tolerance is not limited to undeveloped
DCs, however fully mature DCs are able to induce tolerance
which ultimately results in the establishment of long-term
chronic infection (Lutz and Schuler, 2002). Moreover, contact of
immature DCs with CD4+ naïve T cells may induce regulatory
T-cell action of Tregs and prevents Th1 response in a TGF-
β-dependent manner, this incidence was previously recorded
during human chronic brucellosis (Elfaki and Al-Hokail, 2009).
Additionally, Brucella infected macrophages activate DCs to
present antigen which stimulates immune response of host
(Billard et al., 2007). Ineffective contact of CD4+ T cells with
immature DCs results in failure in delivery of licensing signals
required for CD8+ cytotoxic T cell stimulation. Reduction in
the level of IL-10 indicates an improvement in host resistance
mechanism to brucellosis (Smith et al., 2004). These findings
suggest that Brucella hinder antigen presentation, and have
significant role in the interplay between innate and adaptive
immune mechanisms.
Brucella LPS has noncononical structural differences that
play important roles in its stealthy behavior which in turn
helps in the initiation of the adaptive immune response and
antigen presentation to T cells (Conde-Alvarez et al., 2012). LPS
forms macrodomain clusters after recycling from compartments
that are specialized sites for antigen loading and processing
to macrophage cell surface. These macrodomain clusters are
composed of Brucella LPS, MHC class II molecules and lipid
rafts. MHC class II molecules form complexes that facilitate
the initiation of immune response (Lapaque et al., 2006).
Indeed, purified Brucella LPS is capable of inhibiting peritoneal
macrophages presentation of ovalbumin and hen egg lysozyme
antigenic peptides to specific T-cell hybridomas in the presence
of MHC class II (Forestier et al., 2000). At the plasma membrane
of peritoneal macrophages, Br-LPS moieties sequester with MHC
class II molecules where their biogenesis occurs in lysosomes.
Similarly, in B lymphocytes, these Br-LPS moieties also aggregate
in the MHC class II compartments (Figure 2; Forestier et al.,
1999). B-cell proliferation is initiated by the secretion of Brucella
virulence factor prpA that interact with macrophages and
release several soluble factors necessary for establishing chronic
infection (Spera et al., 2006, 2013). In addition to this, Brucella
change the cytokine level of IFN-γ, TNF-α, IL-10 and TGFβ1 in
the early stages of brucellosis in a prpA dependent manner (Spera
et al., 2014). Recent studies clarify the roles of Btp1/TcpB, Br-
LPS and PrpA as being significant immunomodulatorymolecules
with the ability to interplay with host immune mechanisms.
Furthermore, they have capability to inhibit the secretion of IFN-
γ and increase the secretion of IL-10 that affects Th1 immune
response (Wang et al., 2012).
Brucella effector molecules are capable of controlling TLR
signaling pathway that involved in DC maturation with
significant effects on T-lymphocyte activation and antigen
presentation. Brucella TIR protein 1 (Btp1) shows sequence
resemblances with Toll/IL-1 recptors (TIR) domain family.
Different studies investigated the role of Btp1 in DC maturation
due to significance of TIR domain in the TLR signaling (Kenny
and O’Neill, 2008; Atluri et al., 2011). Btp1 inhibits both the
production of proinflammatory cytokines and DC maturation
that leads to inhibition of TLR2 and TLR4 signaling (Salcedo
et al., 2008; Atluri et al., 2011). Brucella lumazine synthase also
induces negative effect by blocking TLR4-MD2 complex (Rossi
et al., 2015). Btp1/TcpB bind adapter TIRAP at the cell membrane
and block NF-κB activation (Radhakrishnan and Splitter, 2010).
Therefore, Brucella inhibits TLR-signaling pathway to reduce the
function of infected DCs. Recently, it has been demonstrated
that Btp1 associates with host microtubules to protect them
from depolymerization an additional function of this protein
(Radhakrishnan et al., 2011). Additionally, it has been shown that
this protein causes inhibition of CD8+ T-cell killing of Brucella
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FIGURE 2 | Strategies of Brucella to evade the innate and adaptive immunity. Brucella Btp1/TcpB is proposed to act in host cytosol where it interferes with
TLR signaling pathway and facilitates ubiquitination and degradation of Mal which in turn inhibits TLR2 and TLR4 pathway, resulting in inhibition of NF-κB secretion
and lymphocyte activation. On the other hand, the antigen loading compartment, comprised of Br-LPS and MHC class II molecules, is capable of interacting with
functional microdomain which result in lymphocyte activation and inhibition of OVA presentation to CD4+ T cells. Straight arrows indicate the innate immunity
pathways while dashed arrows are related to adaptive immunity pathways.
target cells and represents an adaptive immune evasion strategy
(Durward et al., 2012). Thus, these findings of new effector
proteins that are capable of interaction with TLR signaling
pathway reinforce the notion that Brucella use multiple strategies
to evade host adaptive immune system to establish chronic
infection (Gorvel, 2008).
SELECTIVE SUBVERSION OF AUTOPHAGY
PATHWAY
Autophagy, “self-eating,” contributes to several cellular and
organism homeostatic mechanisms by capture of cytosolic
components, damaged organelles such as mitochondria,
protein aggregates (Kraft and Martens, 2012), and intracellular
bacteria (whether cytosolic or vacuolar) into specialized double-
membrane vacuoles called autophagosomes (Yang and Klionsky,
2010). Even though, autophagy is initially found in nutrient
reprocessing in response to starvation, some other cellular and
oxidative stress functions are well recognized in the induction
of autophagy pathway and also contribute to innate immune
response (Levine et al., 2011) through antibacterial activities.
Intracellular pathogens adopt different strategies for
involvement in the host autophagic pathway that include
damage to the membrane, hiding to avoid recognition by the
autophagy mechanism and development of replicative niches
(Bestebroer et al., 2013).
For the development of Brucella replication (rBCV) fusion
of endoplasmic reticulum with endocytic compartment occurs
in the Sar1- and Rab2- dependent manner. In macrophages
and epithelioid cells during early stages of brucellosis, rBCV
convert into a specialized property compartment known as
autophagic BCV (aBCV). Recent evidence supports the theory
that autophagy-associated proteins play a key role in the
biogenesis of rBCV and contribute to completion of intracellular
life cycle, Brucella subverts the host cell membrane trafficking
pathways (Starr et al., 2008, 2012).
However, rBCV to aBCV conversion depends upon autophagy
initiation proteins for example BECLIN1, PI3K, ULK1, and
Atg14L but independently of autophagy elongation proteins such
as Atg5, Atg7, LC3B, Atg4B, and Atg16L1 that are necessary
for abolishing the autophagosome formation (Starr et al., 2012).
The mechanism involved is still not clearly explained, other
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studies suggest that ULK1 and Beclin 1 are required for non-
canonical pathways but independent of LC3 and Atg7, as
well as Atg5 recruitment (Collins et al., 2009; Nishida et al.,
2009). Furthermore, aBCV formation depends upon the small
GTPase Rab9 which is not required in HeLa cells (Starr
et al., 2012). Autophagosome maturation initiates into endocytic
compartment when BECLIN1 and PI3K form a complex, but
depletion in ATG14L leads to decreased aBCV formation
which starts from the endoplasmic reticulum-localized BECLIN1
complex. Recent studies support the non-canonical autophagy
pathway playing a key role in host-pathogen interaction, and have
common upstream regulators with canonical autophagy pathway
(Starr et al., 2012). The egress mechanism is helpful in pathogen
release and cell-to-cell spread in which Atg proteins play a
significant role in this process (Duran et al., 2010;Manjithaya and
Subramani, 2011).
There are some new insights about the role of unfolded
protein response (UPR) and autophagy in Brucella replication
and rBCV biogenesis (de Jong et al., 2013; Celli and Tsolis, 2015),
such as activation of IRE1α in macrophages and HeLa cells by
B. abortus (Taguchi et al., 2015), while ATF6, PERK and IRE1α
in the instance of B. melitensis infection (Smith et al., 2013).
The UPR pathways activation by Brucella also supports the idea
that IRE1α is important in the bacterial replication (Qin et al.,
2008). Yip1A is a host protein that leads to phosphorylation of
IRE1α in brucellosis and binding with COPII for localization
into Endoplasmic reticulum exist sites. Furthermore, Yip1A and
IRE1α are essential for Brucella replication and rBCV biogenesis
(Taguchi et al., 2015). There is up regulation of Sar1 and COPII
by Yip1A-dependent activation of IRE1α, results in formation
of large vacuoles that depend upon ATG9 and WIPI (Taguchi
et al., 2015). These findings clarify the role of IRE1α in brucellosis
and facilitate the formation of autophagic origin vacuoles that
convert endosomal brucella-containing vacuole (eBCV) into
rBCV (Figure 1;Wang et al., 2014).
It is also observed that UPR activation in the Brucella-infected
macrophages via TcpB facilitates protein folding that affects
Brucella intracellular growth (Smith et al., 2013). In addition to
this some effectors, such as BspC, BspK, BspH, and BspG, can also
enhance the endoplasm reticulum stress by ecoptic expression
in HeLa cells (Myeni et al., 2013). These results show that
the initiation of autophagy proteins is important in conversion
of rBCV to aBCV while Yip1A is also required in Brucella
replication and rBCV biogenesis. Hence, this is an essential
strategy used by Brucella to combat with host immune response
for which further study is required to investigate the involvement
of autophagy in Brucella pathogenesis as well as in innate and
adaptive immune mechanisms.
INHIBITION OF APOPTOSIS
Apoptosis is an extremely well-regulated manner of programmed
cell death, which is generally facilitated by the initiation of
caspases, and excellent host defense response against intracellular
bacteria. However, inhibition of apoptosis is another strategy
of Brucella to maintain intracellular niche for its replication.
Brucella inhibits apoptotic mechanism in infected macrophages
with the induction of chemical stimuli (Gross et al., 2000).
Furthermore, in B. melitensis infection there is down regulation
of genes involved in apoptotic pathway in mitochondria (He
et al., 2006). There is significant increase in Nedd4 activity
during brucellosis in a specific calcium-dependent manner.
Brucella-infected macrophages treated with Nedd4 decrease this
activity that in turn stops calpain 2 degradation and leads to
macrophages apoptosis (Cui et al., 2014). Caspase-2 is involved
in the regulation of many genes and pathways which prompts
macrophage death that is an important feature of apoptosis and
pyroptosis (Bronner et al., 2013). Moreover, upregulation of A20
leads to inhibition of NF-κB that limiting caspase-8-dependent
macrophage cell death and favors intracellular growth of bacteria
(Wei et al., 2015).
Another important strategy that is employed involves
the interaction of Brucella-macrophage to enhance virulence
by inhibiting macrophage cell death. After the invasion of
smooth Brucella into macrophages for replication, the pathogen
automatically converts into rough mutants that can results
in macrophage cytotoxicity that favors bacterial egress and
dissemination (Pei et al., 2014). B. abortus 2308 rough mutants
that lack of surface LPS exhibited failure in the inhibition of
apoptosis (Pei et al., 2006), because this depends upon T4SS and
is associated with the effect of LPS inhibiting TLR signaling (Pei
et al., 2008).
Brucella lipoprotein increases T cells apoptosis which depends
upon TNF-α secretion, sheding light on mechanisms that
Brucella uses to directly inhibit T cells responses, involved in
adaptive immune evasion (Figure 3; Velasquez et al., 2012).
Additionally, Brucella- infected neutrophils and monocytes have
obvious upregulation of various adhesion molecules such as
CD106 and CD54 that result in inhibition of apoptosis in
brucellosis (Scian et al., 2013). Altogether this evidence indicates
that apoptosis inhibition is a strategy of Brucella for intracellular
replication that in turn facilitates evasion of the immune
response.
PUTATIVE ROLE OF SMALL NONCODING
RNA AGAINST BRUCELLA STEALTH
STRATEGY
MicroRNAs are part of small noncoding RNA involved in
regulation of gene expression and in cellular mechanisms,
apoptosis and signal transduction (He and Hannon, 2004;
Djuranovic et al., 2012; Leung and Sharp, 2013). Even though, we
are still at the initial stages of knowing the role of miRNAs and
how they develop and regulate the immune mechanisms, recent
evidence found that miRNAs play a pivotal role in immunity
such as miR-181a and miR-223 in establishing and maintaining
immune cells (Chen et al., 2004; Matsushima et al., 2011), miR-
146 regulate TLR signaling and cytokine response in innate
immunity (Tili et al., 2007). Furthermore, they are involved
in adaptive immunity associated antigen presentation such as
miR-155 (Schulte et al., 2013), and miR-181a in T cell receptor
signaling (Iliopoulos et al., 2010).
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FIGURE 3 | Overview of stealth strategies of Brucella. TLR signaling pathway is involved in the recognition of Brucella which mediates the secretion of TNF-α and
IL-12 by DCs and Møs during the initial stages of infection that favor intracellular survival and replication. Brucella produces Btp1/TcpB protein that inhibits TLR2/4
signaling pathway while flagellin inhibits TLR5. Brucella LPS O-antigen binds with C3 preventing activation of complement cascade. Brucella inhibits activation of NK
cells and neutrophil degranulation to interfere with innate immune response of host. Btp1/TcpB produced by this bacteria inhibit dendritic cells maturation, and
Brucella LPS inhibits of antigen presentation, coupled together ultimately interfere with innate and adaptive immunity of host facilitating chronic infection. Brucella
lipoprotein increases apoptosis of T cells which is dependent upon TNF-α secretion that directly inhibits the T cell response. Furthermore, Brucella inhibits
macrophage apoptosis and autophagolysosomal fusion which are among the key stealth strategies of this pathogen. The final consequence of interfering with these
mechanism results in the clinical manifestations of human brucellosis and in the natural hosts.
Brucella adapt diverse environmental conditions and use
multiple strategies to evade host cell defense. It would seem
that Brucella sRNA may play a significant role in bacterial
responses to stress. Hfq protein mediates most of the sRNA-
mRNA interactions which is required for virulence and to
control bacterial stress response in pathogen–host interactions
(Papenfort and Vogel, 2010; Hanna et al., 2013) as well in Brucella
stress response (Robertson and Roop, 1999). A recent finding
also supports the involvement of hfq in pathogenicity associated
invasion and proliferation within host cell as illustrated by a
B.melitensis hfq mutant (Cui et al., 2013).
Casewell et al. reported that B. abortus sRNAs, abcR1 and
abcR2 play essential roles in pathogenicity and in chronic
infection, resulting in a significant decrease in intracellular
survival in a mouse model and in macrophages as well (Caswell
et al., 2012). Transcriptional regulators like gntR code for
miRNAs required for Brucella virulence. However, their inhibited
expression within macrophages led to decreased Brucella
intracellular survival indicating that miRNAs are essential for the
adaptation to stress conditions and ultimately cause modulation
of Brucella intracellular survival (Wang et al., 2015).
Inhibited expression of syntaxin mRNA with small interfering
RNAs modulated initial phagocytosis and intracellular survival
of Brucella (Castaneda-Ramirez et al., 2015). We studied the
expression of miRNAs in B. melitensis-infected cells and found
several miRNAs such as miR-92a, miR-93, let-7b, miR-1981, and
miR-181b differentially expressed compared to mock-infected
cells, and purposed that these miRNAs might be involved in
immune response mechanisms, autophagy and apoptosis (Zheng
et al., 2012). These reports shed light on the importance of small
noncoding RNA in immunity, but further studies will be required
to more fully understand the involvement and mechanism of
miRNAs in modulating the host immune response as well as
miRNA-based strategies used by Brucella for immune evasion.
SUMMARY AND PERSPECTIVES
Although in brucellosis humans are infected as incidental host,
approximately 500,000 new cases reported annually, yet no
patient-friendly treatment or effective vaccines available for
humans. Additionally, Brucella spp. shows deliberate release
through direct discharge to poses risk to public health. Brucella
has remarkable strategies enabling avoidance of the host immune
response and facilitating the establishment of chronic infections.
However, for survival the host cells have developed complex
immune mechanisms to defeat and battle against pathogens
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and maintain a balance between host resistance and Brucella
virulence. During the intracellular replication Brucella shows
typical tissue tropism for lymphoreticular and reproductive
systems that helps in evasion of innate and adaptive immune
mechanism of host to establish clinical disease manifestations
and pathogenesis. At the early stage of infection symptoms
observed in humans includes, fatigue, pyrexia, anorexia, myalgia
and diaphoresis. However, during chronic stage of brucellosis,
persistence occurs in the tissues of mononuclear phagocyte
system including bone marrow, lymph nodes, liver and spleen.
Likewise it also persists in male reproductive organs, placenta
and fetus. At early process of infectious pathogenesis, Brucella
modulate the immune response mechanism of host to quickly
translocate through mucosal immune barrier and is endocytosed
by mucosal macrophages and DCs. Stealthy brucellae use
different type of strategies to establish and maintain chronic
infection by fusion of type IV secretary system dependent BCVs
with lysosome to evade intracellular destruction. Brucella infects
the host cell and protects itself by limiting PRRs including
complement system and TLR signaling pathways. Brucella LPS
shows non-cononical structural differences that inhibit antigen
presentation to T cells and dampens innate and adaptive immune
mechanisms. Moreover, Brucella LPS inhibits activation of DCs
to subvert the immune response and establish protective Th1
immune response by secreting IL-12 and preventing T-cell
stimulatory action. Brucella modulates MHC-I and MHC-II
expression prompted by IFN-γ which depend upon cytokine
regulation. In addition, Brucella uses multiple strategies such
as cloaking to avoid recognition by the autophagy mechanism
and development of replicative niches. Furthermore, inhibition
of apoptosis is another strategy of Brucella to evade the immune
response to establish chronic infection.
Once Brucella adapted to the intra-macrophage environment
it extends intracellular replication to reach other systems
preferably to target cells and tissues such as skeletal tissues, male
genitalia, placental trophoblasts, reticuloendothelial system and
endothelium. Newly identified protein UPR and Btp1/TcpB are
also important in innate immune evasion during early stages
of infection. Recent evidence suggests that Yip1A and IRE1α
are essential for Brucella replication and rBCV biogenesis that
ultimately supports nutrient acquisition and pathogen cell-to-
cell spread. Even though numerous strategies employed by
Brucella to evade the immune response have been identified,
there are many questions that need to be answered in respect
to other “stealth” mechanisms. What mechanism is involved in
apoptosis inhibition by Brucella in infected host cells remains
to be clarified? How do miRNAs interfere with innate and
adaptive immune response mechanisms? How miRNAs cause
modulation in Brucella intracellular survival? What is the role
of miRNAs in autophagy and apoptosis mechanism will be an
open question for the next few years. In depth understanding
of the “stealth” strategies used by this pathogen will facilitate
focus on the pathogenicity of bacterium and development of
novel effective therapeutic approaches to treat brucellosis in the
future.
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